<DOC>
	<DOCNO>NCT02241941</DOCNO>
	<brief_summary>The purpose study determine single dose pharmacokinetics daptomycin consecutively 10 patient three different time point severe burn injury .</brief_summary>
	<brief_title>Evaluation Single-dose Pharmacokinetics Intravenous Daptomycin Patients With Thermal Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Burns</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<criteria>Male female 18 year old Second and/or third degree thermal injury Total body surface area burn ≥ 15 % Hospitalisation ICU burn injure patient University Hospital Zürich Probability ICU stay &gt; 14 day Written inform consent patient patient unable informed sign accord section 4.4 study protocol Evidence renal failure ( Creatinine clearance &lt; 30ml/min ) continuous renal replacement therapy continuous hemofiltration History muscle disease skeletal muscle disorder Creatinephosphokinase ( CPK ) ≥ 5 time upper limit normal ( ULN ) History hypersensitivity drug Pregnancy Severe coagulation disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>